Inspire Medical Systems Inc. (INSP) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Inspire Medical Systems I... (INSP)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

169.94

-5.49 (-3.13%)

At close: Jan 14, 2025, 3:59 PM

168.50

-0.85%

Pre-market Jan 15, 2025, 04:46 AM EST

undefined% (undefined)

Bid	154.28
Market Cap	5.09B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	1.11
PE Ratio (ttm)	153.1
Forward PE	n/a
Analyst	Buy

Ask	271.98
Volume	660,944
Avg. Volume (20D)	527,054
Open	176.84
Previous Close	175.43
Day's Range	168.74 - 179.95
52-Week Range	123.00 - 257.40
Beta	undefined

About INSP

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a pa...

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date May 3, 2018

Employees 1,011

Stock Exchange NYSE

Ticker Symbol INSP

Website https://www.inspiresleep.com

Analyst Forecast

According to 11 analyst ratings, the average rating for INSP stock is "Buy." The 12-month stock price forecast is $240, which is an increase of 41.23% from the latest price.

Buy 72.73%

Hold 27.27%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Inspire Medical Systems Inc. is scheduled to release its earnings on Feb 10, 2025, after market closes.
Analysts project revenue of $232.90M, reflecting a 20.98% YoY growth and earnings per share of 0.72, making a 46.94% increase YoY.

Why Price Moved

2 days ago · Source

-13.36%

Inspire Medical Systems shares are trading lower a... Unlock content with Pro Subscription

3 weeks ago · Source

-0.1%

Inspire Medical shares are trading lower after rival Eli Lilly received approval for Zepbound as an obstructive sleep apnea treatment for obese adults.

News

23 hours ago · zacks.com

Inspire Medical Stock Falls Despite Solid Preliminary Q4 Revenues

INSP's revenue growth in the fourth quarter is likely to have been boosted by increased market penetration in existing centers and expansion into new implanting centers.

1 week ago · zacks.com

Why Inspire Medical Systems (INSP) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

3 weeks ago · investopedia.com

Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound

Shares of ResMed (RMD) and Inspire Medical Systems (INSP) fell Monday as the companies behind products to treat sleep apnea faced a new threat from weight-loss drugs.

1 month ago · businesswire.com

Presidio Medical™ Announces Appointment of Richard J. Buchholz to Join its Board of Directors

SAN MATEO, Calif.--(BUSINESS WIRE)-- #backpain--Presidio Medical, Inc., a clinical stage company developing a transformational neuromodulation platform, is pleased to announce Richard J. Buchholz will...

1 month ago · zacks.com

5 Growth Stocks to Buy in December for Impressive Short-Term Upside

These five growth stocks have strong potential for December. These are: MNDY, PSN, PI, INSP, INGR.

1 month ago · zacks.com

5 Medical Info System Stocks to Buy for a Stable Portfolio in 2025

Five medical info systems stocks have strong potential for 2025. These are: INSP, OMCL, TALK, BFLY, CLOV.

1 month ago · benzinga.com

Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade

BofA Securities has upgraded Inspire Medical Systems, Inc. INSP and says the company now falls in the profitable growth category.

2 months ago · zacks.com

INSP Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts

Inspire Medical's both geographic segments witness strong revenue growth on the back of solid product demand in the third quarter.

2 months ago · seekingalpha.com

Inspire Medical Systems, Inc. (INSP) Q3 2024 Earnings Call Transcript

Inspire Medical Systems, Inc. (NYSE:INSP ) Q3 2024 Earnings Conference Call November 4, 2024 5:00 PM ET Company Participants Ezgi Yagci – Vice President-Investor Relations Tim Herbert – President and ...

2 months ago · zacks.com

Here's What Key Metrics Tell Us About Inspire (INSP) Q3 Earnings

Although the revenue and EPS for Inspire (INSP) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Str...

2 months ago · zacks.com

Inspire Medical Systems (INSP) Q3 Earnings and Revenues Surpass Estimates

Inspire Medical Systems (INSP) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to loss of $0.29 per share a year ago.

2 months ago · zacks.com

Seeking Clues to Inspire (INSP) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics

Evaluate the expected performance of Inspire (INSP) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metric...

2 months ago · zacks.com

Zacks Industry Outlook Medical Systems, 10x Genomics and Omnicell

Medical Systems, 10x Genomics and Omnicell have been highlighted in this Industry Outlook article.

2 months ago · zacks.com

3 Medical Info Systems Stocks to Gain From Healthcare Digitization

Zacks Medical Info Systems industry stocks like Inspire Medical Systems, 10x Genomics and Omnicell are expected to gain from the GenAI wave.

2 months ago · zacks.com

Inspire (INSP) Upgraded to Buy: What Does It Mean for the Stock?

Inspire (INSP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.